Quotient Biodiagnostics
Newtown
About Quotient Biodiagnostics
Quotient Biodiagnostics is focused on providing high quality, high value immunohematology products to hospitals and blood banks in the US. Through its wholly-owned subsidiary, Alba Bioscience, Quotient offers more than 30 years of research, development and manufacturing of transfusion diagnostics products that traditionally have been sold worldwide either directly or by other major transfusion companies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 251 – 500
- Estimated revenue: $1K – $10K
- Total funding: $423.7M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jun 2022)
- Ticker: nasdaq:QTNT
- Website: quotientbd.com
- Phone: +44 131 445 6159
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/quotient-biodiagnostics-150787 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.